top of page

Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children

Updated: Jan 28, 2022

This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal antiretroviral medicines and dosage forms become available.

Related Posts

See All


bottom of page